CD106 (VCAM-1) Antibody, anti-human, REAdye_lease™
Synonyms: VCAM1, INCAM-100
RECOMBINANT
Clone:
REAL273
Type of antibody:
Releasable fluorochromes, Primary antibodies, Recombinant antibodies
Applications:
MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »

Related products for CD106 (VCAM-1) Antibody, anti-human, REAdye_lease™

MICS (MACSima Imaging Cyclic Staining) applications
PE
Fixation:
frozen – Acetone
Species tested:
human
Tissue used:
tonsil
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
PE
Used products:
130-127-042
Testing grade:
Description:
Immunofluorescence analysis of a human tonsil cryosection fixed with ice-cold acetone. The section was stained using CD106 (VCAM-1) Antibody, anti-human, PE (green) for 10 min at room temperature. Nuclei were visualized with Hoechst™ (blue).Scale bar: 30 µm.

Application image
Specifications for CD106 (VCAM-1) Antibody, anti-human, REAdye_lease™
Overview

Clone REAL273 is an antibody fragment derived from the full CD106 (VCAM-1) antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity.

Clone REAL273 recognizes the CD106 (VCAM-1) antigen, a 110 kDa single chain type I glycoprotein also known as vascular cell adhesion protein 1 (VCAM-1) or INCAM-100. CD106 is expressed on inflamed vascular endothelium, as well as on macrophage-like and dendritic cell types in both normal and inflamed tissue. Upregulation of CD106 in endothelial cells by inflammatory stimuli and cytokines occurs as a result of increased gene transcription. Primarily, CD106 is an endothelial ligand for very late antigen-4 (VLA-4) or integrin α-4/β-7 and mediates both adhesion and signal transduction. The interactions play a pathophysiologic role in leukocyte adhesion, transmigration, and co-stimulation of T cell proliferation.

For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).

Alternative names

VCAM1, INCAM-100

Detailed product information

Technical specifications

Clone
REAL273
Clonality
monoclonal
Isotype control
Control Antibody
Host
cell line
Type of antibody
Releasable fluorochromes, Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
CD106 (VCAM-1)
Distribution of antigen
dendritic cells, endothelial cells, macrophages
RRID
AB_2904664
Resources for CD106 (VCAM-1) Antibody, anti-human, REAdye_lease™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for CD106 (VCAM-1) Antibody, anti-human, REAdye_lease™
Publications
  1. Barreiro, O. et al. (2002) Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J. Cell Biol. 157 (7): 1233-1245
  2. Johnson, L. A. et al. (2008) Cell traffic and the lymphatic endothelium. Ann. N. Y. Acad. Sci. 1131: 119-133
  3. Schlesinger, M. et al. (2015) Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis. Int. J. Cancer 136 (11): 2504-2514
  4. Osborn, L. et al. (1992) Activated endothelium binds lymphocytes through a novel binding site in the alternately spliced domain of vascular cell adhesion molecule-1. J. Exp. Med. 176 (1): 99-107